PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer
Open Access
- 28 June 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (53) , 90948-90958
Abstract
PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancerKeywords
This publication has 33 references indexed in Scilit:
- Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancersOncotarget, 2015
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomesNature Medicine, 2015
- PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast CancerJournal of Clinical Oncology, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast CancerCancer Cell, 2007
- Mutation of the PIK3CA oncogene in human cancersBritish Journal of Cancer, 2006
- Mutant PIK3CA promotes cell growth and invasion of human cancer cellsCancer Cell, 2005
- High Frequency of Mutations of the PIK3CA Gene in Human CancersScience, 2004
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002